| Emerging roles of Meis1 in cardiac regeneration, stem cells and cancer M Aksoz, RD Turan, E Albayrak, F Kocabas Current Drug Targets 19 (2), 181-190, 2018 | 32 | 2018 |
| c-Myc inhibitor 10074-G5 induces murine and human hematopoietic stem and progenitor cell expansion and HDR modulator Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... Current cancer drug targets 19 (6), 479-494, 2019 | 30 | 2019 |
| Temporal modulation of calcium sensing in hematopoietic stem cells is crucial for proper stem cell expansion and engraftment M Uslu, E Albayrak, F Kocabaş Journal of cellular physiology 235 (12), 9644-9666, 2020 | 28 | 2020 |
| Development of Small Molecule MEIS Inhibitors that modulate HSC activity RD Turan, E Albayrak, M Uslu, P Siyah, LY Alyazici, BM Kalkan, GS Aslan, ... Scientific reports 10 (1), 7994, 2020 | 26 | 2020 |
| Small molecule‐mediated modulation of ubiquitination and neddylation improves HSC function ex vivo E Albayrak, M Uslu, S Akgol, EC Tuysuz, F Kocabas Journal of Cellular Physiology 236 (12), 8122-8136, 2021 | 11 | 2021 |
| BML‐260 promotes the growth of cord blood and mobilized peripheral blood hematopoietic stem and progenitor cells with improved reconstitution ability E Albayrak, S Akgol, RD Turan, M Uslu, F Kocabas Journal of Cellular Biochemistry 123 (12), 2009-2029, 2022 | 4 | 2022 |
| Competitive inhibition of IL-2/IL-2R has a dual effect on HSC ex vivo expansion and IL-2R (CD25) content M Uslu, E Albayrak, F Kocabaş International Immunopharmacology 110, 109035, 2022 | 3 | 2022 |
| MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis N Meriç, E Albayrak, Z Gülbaş, F Kocabaş Leukemia & Lymphoma 65 (2), 187-198, 2024 | 2 | 2024 |
| Hyperthermia‐stimulated tonsil‐mesenchymal stromal cells suppress hematological cancer cells through downregulation of IL‐6 M Yüce, E Albayrak Journal of Cellular Biochemistry 123 (12), 1966-1979, 2022 | 2 | 2022 |
| Tonsil-derived mesenchymal stem cells inhibit the proliferation of hematological cancer cells through downregulation of IL-6 gene expression under hyperthermia M Yüce, E Albayrak | 1 | 2021 |
| c-Myc inhibition is critical for HSC expansion and Rad51 expression M Aksoz, E Albayrak, GS Aslan, RD Turan, LY Alyazici, P Siyah, ... bioRxiv, 403584, 2018 | 1 | 2018 |
| Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model M Yuce, E Albayrak Applied Biochemistry and Biotechnology, 1-20, 2023 | | 2023 |
| CRISPR/Cas9 system in hematopoietic stem cells: Basic research and clinical applications E Albayrak Journal of Experimental and Clinical Medicine 40 (1), 161-170, 2023 | | 2023 |
| Conditioned media of tonsil derived mesenchymal stem cells shows different rates of cytotoxicity on solid cancer cells Y Melek, E Albayrak, Ç Gümüşkaptan Anatolian Current Medical Journal 5 (4), 503-510, 2023 | | 2023 |
| Therapeutic targeting and HSC proliferation by small molecules and biologicals E Albayrak, F Kocabaş Advances in Protein Chemistry and Structural Biology 135, 425-496, 2023 | | 2023 |
| Comparison of the Anti-Tumor Effect of Conditioned Media of Tonsil-Derived Mesenchymal Stem Cells on A549 and PANC-1 Cancer Cell Lines M Yüce, E Albayrak, Ç Gümüşkaptan | | 2022 |
| Mesenchymal Stem Cell Applications for the Treatment of COVID-19: Clinical Perspective BN Kasapli, S Tepe, T Geçit, E Albayrak, M Yüce Int J Stem Cell Res Ther 9, 077, 2022 | | 2022 |
| Identification of novel hematopoeitic small molecules enables ex vivo hematopoietic stem cell expansion F Kocabas, RD Turan, DD Celik, E Albayrak, M Aksoz, EC Tuysuz, ... FEBS JOURNAL 283, 35-35, 2016 | | 2016 |
